Eisai To Present Latest Data of Lemborexant at 35th Annual Sleep Meeting (SLEEP2021)
TOKYO, Jun 9, 2021 – (JCN Newswire via SEAPRWire.com) – Eisai Co., Ltd. announced today that a total of 5 poster presentations including the latest data on its in-house discovered orexin receptor antagonist lemborexant (product name: DAYVIGO) will be given at the 35th annual meeting of the Associated Professional Sleep Societies (SLEEP 2021), to be... » read more